<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CB05C424-91BF-4B48-9472-E6F6226A6A05"><gtr:id>CB05C424-91BF-4B48-9472-E6F6226A6A05</gtr:id><gtr:name>University of London</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Malet Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/927046A3-9661-42CB-AFB8-F9171A91DDE8"><gtr:id>927046A3-9661-42CB-AFB8-F9171A91DDE8</gtr:id><gtr:name>College of Medicine, Dentistry &amp; Nursing</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E056B67D-9F78-434B-A780-0272249ECB6C"><gtr:id>E056B67D-9F78-434B-A780-0272249ECB6C</gtr:id><gtr:name>Masaryk University</gtr:name><gtr:address><gtr:line1>Zerotinovo nam. 9</gtr:line1><gtr:line4>601 77 Brno</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Czech Republic</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CB05C424-91BF-4B48-9472-E6F6226A6A05"><gtr:id>CB05C424-91BF-4B48-9472-E6F6226A6A05</gtr:id><gtr:name>University of London</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Malet Street</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 7HU</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3606C3ED-A577-408B-B772-36C9080CDAF9"><gtr:id>3606C3ED-A577-408B-B772-36C9080CDAF9</gtr:id><gtr:name>Universite Montpellier</gtr:name><gtr:address><gtr:line1>Service Communication</gtr:line1><gtr:line2>5 bd Henri IV - BP 1017</gtr:line2><gtr:line3>34006 Montpellier Cedex 1</gtr:line3><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/927046A3-9661-42CB-AFB8-F9171A91DDE8"><gtr:id>927046A3-9661-42CB-AFB8-F9171A91DDE8</gtr:id><gtr:name>College of Medicine, Dentistry &amp; Nursing</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E056B67D-9F78-434B-A780-0272249ECB6C"><gtr:id>E056B67D-9F78-434B-A780-0272249ECB6C</gtr:id><gtr:name>Masaryk University</gtr:name><gtr:address><gtr:line1>Zerotinovo nam. 9</gtr:line1><gtr:line4>601 77 Brno</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Czech Republic</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9"><gtr:id>67ABD4F2-1AB0-483C-9F74-C6E9B0460BF9</gtr:id><gtr:name>NHS Lothian</gtr:name><gtr:address><gtr:line1>Royal Victoria Hospital</gtr:line1><gtr:line2>13 Craigleith Road</gtr:line2><gtr:postCode>EH4 2DN</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D11798B4-8613-4CC0-AC2F-D1E7D6A60FF1"><gtr:id>D11798B4-8613-4CC0-AC2F-D1E7D6A60FF1</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7FBEB7DB-C501-43E4-AA19-B0B95B28BDBD"><gtr:id>7FBEB7DB-C501-43E4-AA19-B0B95B28BDBD</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Warnock</gtr:otherNames><gtr:surname>Meek</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EF904DB6-0838-427D-A513-EBFD09816648"><gtr:id>EF904DB6-0838-427D-A513-EBFD09816648</gtr:id><gtr:firstName>Ted</gtr:firstName><gtr:surname>Hupp</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5AB6BEB2-0668-499B-8CBE-06CF7040AFFE"><gtr:id>5AB6BEB2-0668-499B-8CBE-06CF7040AFFE</gtr:id><gtr:firstName>Kathryn Lindsay</gtr:firstName><gtr:surname>Ball</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CFDF7356-44FC-41F4-A127-79B5D05FD467"><gtr:id>CFDF7356-44FC-41F4-A127-79B5D05FD467</gtr:id><gtr:firstName>D</gtr:firstName><gtr:surname>Lane</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DDCB14ED-882F-4CEA-89A0-0C624020297D"><gtr:id>DDCB14ED-882F-4CEA-89A0-0C624020297D</gtr:id><gtr:firstName>Barbara</gtr:firstName><gtr:surname>Spruce</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/17C3F48B-30D4-43E2-97F2-5ABEB4E36C99"><gtr:id>17C3F48B-30D4-43E2-97F2-5ABEB4E36C99</gtr:id><gtr:firstName>Eric</gtr:firstName><gtr:surname>Wright</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3CCBA1A8-712E-4D6A-B4C3-B275B8E6E9EB"><gtr:id>3CCBA1A8-712E-4D6A-B4C3-B275B8E6E9EB</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Donald</gtr:otherNames><gtr:surname>Perkins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9900040"><gtr:id>1E0A788C-BC16-4C54-9325-8CF9FB90275B</gtr:id><gtr:title>The Dundee p53 Pathway cooperative group</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9900040</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-06-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-06-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>663087</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Manchester</gtr:department><gtr:description>Gasteroenterology collaboration with Manchester</gtr:description><gtr:id>B180E20E-E257-4658-A298-1C5F404391D2</gtr:id><gtr:impact>has already resulted in submission of an abstract to the Digestive Disorders Week 2006 in Los Angeles</gtr:impact><gtr:piContribution>A recently begun collaboration (October 2005) with gastroenterologists in Manchester (Levison, Hammond, McLaughlin) on inflammatory bowel disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Masaryk University</gtr:collaboratingOrganisation><gtr:country>Czech Republic</gtr:country><gtr:description>Czech collaboration on antibodies</gtr:description><gtr:id>C2BA1C5E-9C2D-4826-AEA0-0EEF42B628EB</gtr:id><gtr:impact>A collaboration with Borek Vojtesek and Dr Rudolph Nenutil from the Department of Cellular and Molecular Oncology at the Masaryk Memorial Cancer Institute in Brno Czech Republic, is continuing with the testing of antibodies developed by Borek on our tissue arrays.</gtr:impact><gtr:partnerContribution>testing of antibodies developed by Borek on our tissue arrays</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Montpellier</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Pharmacy Montpellier</gtr:department><gtr:description>Montpellier collaboration</gtr:description><gtr:id>679AF1F9-68DD-49B7-ACEE-9DD18BF9CFDA</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>NA</gtr:partnerContribution><gtr:piContribution>Collaborative project with a group in Montpellier headed by Dr Pascale Cohen looking at gene expression profiles that are associated with Tamoxifen resistance in breast cancer. Our study involves the production of tissue micro arrays from breast cancer tissue samples obtained in Dundee and comparing the immunocytochemical staining with the gene expression data generated in France.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London (QMUL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Barts and The London School of Medicine and Dentistry</gtr:department><gtr:description>Renal Cell Carcinoma collaboration</gtr:description><gtr:id>174A686A-660E-49A2-BEAA-738AB068D20C</gtr:id><gtr:impact>resulted in the supply of 250 DNA samples and 7 frozen renal cell carcinomas (tumour and normal) from the bank.</gtr:impact><gtr:piContribution>Collaborations with Dr Tim Crook at the Breakthrough Breast Cancer Centre at the Chester Beatty Laboratories and with Dr Fran Balkwill at the Translational Oncology Laboratory at Barts and the London</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cancer Research UK (ICR)</gtr:department><gtr:description>Renal Cell Carcinoma collaboration</gtr:description><gtr:id>94FEFD49-5C77-42B3-8210-16C59831AF0D</gtr:id><gtr:impact>resulted in the supply of 250 DNA samples and 7 frozen renal cell carcinomas (tumour and normal) from the bank.</gtr:impact><gtr:piContribution>Collaborations with Dr Tim Crook at the Breakthrough Breast Cancer Centre at the Chester Beatty Laboratories and with Dr Fran Balkwill at the Translational Oncology Laboratory at Barts and the London</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Lothian</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Western General Hospital</gtr:department><gtr:description>Joint lymphoma group</gtr:description><gtr:id>8F73159B-C041-4857-A137-4A52870A141C</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>Produced a series of lymphoma tissue micro arrays, using material from both sitesProduced a series of lymphoma tissue micro arrays, using material from both sites</gtr:partnerContribution><gtr:piContribution>A joint lymphoma group, comprising of Professor David Levison and Dr Neil Kernohan from Dundee and Dr John Goodlad from the Department of Histopathology in the Western General Hospital, Edinburgh, have produced a series of lymphoma tissue micro arrays, using material from both sites.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>College of Medicine, Dentistry &amp; Nursing</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Neuroscience</gtr:department><gtr:description>Joint lymphoma group</gtr:description><gtr:id>FAB226AB-9727-48BE-8E05-32C5F65BA6A5</gtr:id><gtr:impact>NA</gtr:impact><gtr:partnerContribution>Produced a series of lymphoma tissue micro arrays, using material from both sitesProduced a series of lymphoma tissue micro arrays, using material from both sites</gtr:partnerContribution><gtr:piContribution>A joint lymphoma group, comprising of Professor David Levison and Dr Neil Kernohan from Dundee and Dr John Goodlad from the Department of Histopathology in the Western General Hospital, Edinburgh, have produced a series of lymphoma tissue micro arrays, using material from both sites.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Confederation of Cancer Biobanks</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>833B51DB-3888-4DC3-A894-7E2D6512C2ED</gtr:id><gtr:impact>The co-ordinator of the Bank, the research scientist and the research nurse have given a number of well received local presentations to members of the public and the wider NHS community. In these talks the rationale for tissue banks, the nature of our activities, and some of the research results are presented.

NA</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>143000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NTRAC Research Nurse</gtr:description><gtr:end>2008-05-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>18799BD5-7FE7-4007-ACA5-6EE1082AFEEC</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2004-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>396000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Renewal of Cancer Tissue Bank</gtr:description><gtr:end>2009-05-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>A13B1A88-4A0D-41C4-A328-4BB50F5937C0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A technique whereby 100?s of paraffin embedded cores are inserted into a single paraffin block in an organised manner. TMA blocks can constructed with either similar or a variety of different tumour types. Although time consuming in manufacture the resulting TMA is a valuable resource for testing new antibodies and is also cost saving in respect of immunohistochemistry reagents and in the comparison of protein expression in different tumours immunostained identically.</gtr:description><gtr:id>AD157610-6C1E-4C83-BDAB-485763108613</gtr:id><gtr:impact>TMA?s have been used in 25 projects and has proved to be a important addition to the Bank?s technical repertoire.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Tissue Micro Array</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/034C73A6-EAA0-48A8-A1EC-2547315C91F7"><gtr:id>034C73A6-EAA0-48A8-A1EC-2547315C91F7</gtr:id><gtr:title>BCL2 gene abnormalities define distinct clinical subsets of follicular lymphoma.</gtr:title><gtr:parentPublicationTitle>Histopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/90a00be5bc23ea46d3915e17ef5d06a2"><gtr:id>90a00be5bc23ea46d3915e17ef5d06a2</gtr:id><gtr:otherNames>Goodlad JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0309-0167</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8DB56807-93B9-4577-A0AD-52FF344D2A68"><gtr:id>8DB56807-93B9-4577-A0AD-52FF344D2A68</gtr:id><gtr:title>Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/219d56cd76120bc903d6b615894bf0fb"><gtr:id>219d56cd76120bc903d6b615894bf0fb</gtr:id><gtr:otherNames>Finlan LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9900040</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>208C592B-C1B7-4E87-A19A-04E8D9458E50</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>6.9  Resources and infrastructure (evaluation of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>